Cargando…

Building the basis for proteomics in personalized medicine for targeted treatment

Detalles Bibliográficos
Autores principales:	Kwon, Ho Jeong, Fehniger, Thomas E., Marko-Varga, György
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896889/ https://www.ncbi.nlm.nih.gov/pubmed/27271879 http://dx.doi.org/10.1186/s40169-016-0096-3

Ejemplares similares

Monitoring targeted drug delivery: a key cornerstone of precision medicine
por: Marko-Varga, György, et al.
Publicado: (2012)

Analytical Validation Considerations of Multiplex Mass-Spectrometry-Based Proteomic Platforms for Measuring Protein Biomarkers
por: Boja, Emily S., et al.
Publicado: (2014)

Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
por: Rezeli, Melinda, et al.
Publicado: (2011)

Merging clinical chemistry biomarker data with a COPD database - building a clinical infrastructure for proteomic studies
por: Eriksson, Jonatan, et al.
Publicado: (2017)

BioBanking as the central tool for translational medicine CTM issue 2013
por: Marko-Varga, György
Publicado: (2013)

Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine
por: Marko-Varga, György, et al.
Publicado: (2012)

Biobank resources for future patient care: developments, principles and concepts
por: Végvári, Ákos, et al.
Publicado: (2011)

Chemical proteomics, an integrated research engine for exploring drug-target-phenotype interactions
por: Kwon, Ho Jeong, et al.
Publicado: (2018)

BioBanking - The Holy Grail of novel drug and diagnostic developments?
por: Marko-Varga, György
Publicado: (2011)

Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging
por: Végvári, Ákos, et al.
Publicado: (2016)

Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
por: Sugihara, Yutaka, et al.
Publicado: (2018)

A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types
por: Kato, Yasufumi, et al.
Publicado: (2015)

The international effort: building the bridge for Translational Medicine: Report of the 1st International Conference of Translational Medicine (ICTM)
por: Chen, Xiaoming, et al.
Publicado: (2012)

Development and promotion in translational medicine: perspectives from 2012 sino-american symposium on clinical and translational medicine
por: Qian, Mengjia, et al.
Publicado: (2012)

Therapeutic Targets and Personalized Medicine in Cardiac Disease
por: Vafiadaki, Elizabeth, et al.
Publicado: (2023)

Are we failing to “build on the scientific basis of medicine?”
por: Coderre, Sylvain, et al.
Publicado: (2018)

Fine Mapping the Spatial Distribution and Concentration of Unlabeled Drugs within Tissue Micro-Compartments Using Imaging Mass Spectrometry
por: Nilsson, Anna, et al.
Publicado: (2010)

Variable Drug-Target Exposure, Tumor Signatures, and Combinatorial Targeted Treatment: Approaches of Personalized Medicine in Breast Cancer
por: Schroth, Werner, et al.
Publicado: (2022)

Personalized nanomedicine: future medicine for cancer treatment
por: Shiekh, Farooq A
Publicado: (2013)

Complementary Medicine—Is There a Reasonable Basis for Dialogue?
por: Brewin, T B
Publicado: (1996)

Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas
por: Kelemen, Olga, et al.
Publicado: (2020)

Chemical Basis of Traditional Medicines and New Potential Applications
por: Long, Chunlin, et al.
Publicado: (2014)

Semi-automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies
por: Malm, Johan, et al.
Publicado: (2015)

Personalized Medicine in Oncology; a Special Issue of the Journal of Personalized Medicine
por: VanderWalde, Ari
Publicado: (2021)

Preventive Medicine as a Factor in Empire Building
Publicado: (1904)

Clinical proteomics: a driving force for cancer therapeutic target discovery and precision medicine
por: Wang, Hao, et al.
Publicado: (2019)

Proteomics, Personalized Medicine and Cancer
por: Su, Miao, et al.
Publicado: (2021)

Life and Mind on the Basis of Modern Medicine
Publicado: (1881)

2DDB – a bioinformatics solution for analysis of quantitative proteomics data
por: Malmström, Lars, et al.
Publicado: (2006)

Personalized medicine for schizophrenia
por: Buckley, Peter F., et al.
Publicado: (2017)

Pharmacogenomics and Personalized Medicine
por: Cecchin, Erika, et al.
Publicado: (2020)

Personalized Medicine in Epidemics
por: Middelburg, Rutger A.
Publicado: (2022)

Personalized Medicine: Pharmacokinetics
por: Daali, Youssef
Publicado: (2022)

Leading New Frontiers in Vulva Cancer to Build Personalized Therapy
por: Corrado, Giacomo, et al.
Publicado: (2022)

Personalizing medicine: a systems biology perspective
por: Deisboeck, Thomas S
Publicado: (2009)

Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study
por: Truedsson, Mikael, et al.
Publicado: (2016)

Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases
por: Iso, Hiroyasu
Publicado: (2011)

Personalized Medicine for Liver Disease: From Molecular Mechanisms to Potential Targeted Therapies
por: Bell, Aaron W.
Publicado: (2022)

From Evidence-based Medicine to Personalized Medicine
por: Lee, Suk-Hwan
Publicado: (2012)

Personalized Medicine: A Tailor Made Medicine
por: Akhondzadeh, Shahin
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3jmhh2o6ialblkj8p7sprottid